ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

SURVEY: Cognitive Impairment II

Top 3 Nutrients to Detox the Liver and Soothe Digestion

Natural Bladder Control, Go Less and Live More

Study bodes well for low-carb eaters

Top Vitamin and Mineral Deficiencies — Are You at Risk?

Vital Molecule Increases Cellular Energy and Improves Cognitive Function

Omega Fix for Obesity: How the Right Fats Fight Fat

Potential of Quercetin in the Treatment of Melanoma

How Pomegranate May Protect Against Cancer

Trimming the spare tire: Canola oil may cut belly fat

 
Print Page
Email Article

Trials of Omega-3 Fatty Acids in Treatment of Adult and Adolescent Depression - Recruiting in Boston and Los Angeles

  [ Not Yet Rated ]   [ Discuss This Article ]
By ProHealth.com • www.ProHealth.com • August 29, 2008


Two U.S. medical centers with major depression research programs are recruiting for trials of omega-3 fish oil supplementation - the first for adults ages 18 to 80, and the second for young people ages 12 to 21.

1. Trial of Omega-3 Fatty Acids in Treatment of Depression - Massachusetts General Hospital, Boston

This 8-week, phase III supplementation study - Safety and Effectiveness of Omega 3-Fatty Acids, EPA Versus DHA, for the Treatment of Major Depression - is recruiting men and women ages 18 to 80 diagnosed with current major depressive disorder. (Note: This is one of seven depression studies currently underway at the Depression Clinical Research Program at Mass General. To read about others, click here.)

All patients taking part in the study will also receive 3 months of free follow-up care.

According to the study description:
This research study examines the difference in the effectiveness of two natural compounds, eicosapentanoic (EPA) and docosahexanoic (DHA) omega-3 fatty acids, in treating major depressive disorder. Both types of omega-3 fatty acids are commonly found in fish oils, such as salmon, mackerel and tuna, as well as other marine sources. It is believed that a deficiency in these omega-3 fatty acids may lead to the development of major depression.

The research study lasts for 8 weeks and involves 4 visits after the screen and baseline visits (every two weeks). If eligible, participants will be randomly placed into one of three groups:

• People in the first group will take 1g/day of EPA omega-3 fatty acid,

• Those in the second group will take 1 g/day of DHA omega-3 fatty acid, and those in the third group will take a placebo (a sugar-like pill with no active ingredient).

This research study is double-blind, which means that neither you nor the doctor nor any of the research staff will know which group you are in.

At the end of this 8-week period you will be offered 3 months of follow-up care at no cost to you at the Depression Clinical and Research Program.

If interested, please contact Dan Johnson at djohnson31@partners.org or at 617-724-3673

For more details, read the ClinicalTrials.gov listing for this trial (No. NCT00361374)

* * * *

2. Trial of Omega-3 Fatty Acids for Treatment of Depression in Adolescents (Polyunsaturated Fatty Acids - PUFA) - Cedars-Sinai Medical Center, Los Angeles

The aim of this study is to test the benefit of a combination of cognitive behavior therapy and fish oil supplementation versus cognitive behavior therapy and placebo in adolescents diagnosed with major depression.

The study, conducted by Cedars-Sinai’s Department of Psychiatry and Behavioral Neurosciences, is recruiting patients of both sexes, ages 12 to 21. Patients currently being treated effectively with antidepressants will not be eligible.

According to the study description:

Adolescence is the highest risk period for depression onset. More than 1.3 million youths suffer from major depression annually in the United States, and there is evidence for an increasing trend.

Because many adolescents have their first depressive episode in adolescence, and adolescent depression often leads to recurrent mood disorders in adults, effective treatment during early illness can minimize the negative consequences of initial and repeated episodes.

Although some antidepressants (particularly SSRIs) are effective treatments for juvenile depression, recent warnings about suicide and the use of SSRIs highlight the need for new and safe treatment for juvenile depression.

Data in adults suggest that supplementation with polyunsaturated fatty acids (PUFA) might be useful for the treatment of depression. The purpose of this study is to investigate the safety and efficacy of PUFA for the treatment of adolescent depression.

Contact Information: Lana Levi, 310-423-0744, LeviL@cshs.org

For more detail, read the Clinical Trials.gov listing for this study - Treating Adolescent Depression with Fish Oils (No. NCT00658476).

To read about other depression trials at Cedars-Sinai, and their “Treatment-Resistant Depression Registry,” click here.




Post a Comment

Featured Products From the ProHealth Store
Optimized Curcumin Longvida® Energy NADH™ 12.5mg FibroSleep™


Article Comments



Be the first to comment on this article!

Post a Comment


 
Natural Pain Relief Supplements

Featured Products

Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%

Natural Remedies

Complete and Natural Menopause Relief Complete and Natural Menopause Relief
Energy Breakthrough - One Fibromyalgia Patient’s Fortuitous Discovery Energy Breakthrough - One Fibromyalgia Patient’s Fortuitous Discovery
Irritable Bowel Syndrome: Unlocking the Secrets of Peppermint, Acacia and Fennel Irritable Bowel Syndrome: Unlocking the Secrets of Peppermint, Acacia and Fennel
Olea25 Olive Hydroxytyrosol Hits Astonishing 68,000+ ORAC Antioxidant Value Olea25 Olive Hydroxytyrosol Hits Astonishing 68,000+ ORAC Antioxidant Value
The Guaifenesin Story: A centuries-old bark extract used for clearing the airways – now key to a popular FM symptom-reversal protocol The Guaifenesin Story: A centuries-old bark extract used for clearing the airways – now key to a popular FM symptom-reversal protocol

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map